Clinical trial Recruiting at 1 site Observational Ages 18 to 120

Observational study on Vitamin C Injektopas® for vitamin C deficiency

Official title: Observational Study on Vitamin C-Injektopas® 7.5g in Patients With Vitamin C Deficiency Due to Acute and Chronic Diseases

Run by Pascoe Pharmazeutische Praeparate GmbH · NCT06983847 · Data updated 2026-11-12

This study is testing how well Vitamin C Injektopas® helps people with vitamin C deficiency feel better over time and if they can handle the treatment.

Quick facts

Study typeObservational
Ages18 Years to 120 Years
SexAll
Enrollment1000 (estimated)
SponsorPascoe Pharmazeutische Praeparate GmbH
Industry-sponsored
Locations1 site (Vienna, Etc., Austria)
StatusRecruiting
StartedJanuary 12, 2019
Main results expectedJanuary 12, 2028
Study endsNovember 14, 2028
Registry record updatedSeptember 17, 2026
Trial IDNCT06983847 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have been diagnosed with vitamin C deficiency.

Probably not a fit

Patients with hypersensitivity to the active ingredient, renal insufficiency, or certain blood disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to document the use of Vitamin C Injektopas® 7.5g in patients diagnosed with vitamin C deficiency, either through laboratory tests or clinical symptoms. It will assess how symptoms related to vitamin C deficiency change over time and evaluate the tolerability of the treatment. The study will include patients with both acute and chronic diseases that lead to vitamin C deficiency, focusing on various symptoms such as fatigue, susceptibility to infections, and issues related to collagen formation. The overall efficacy and tolerability of the therapy will also be evaluated through patient surveys.

Why it matters

Potential benefit: If successful, this study could improve the management of vitamin C deficiency and its associated symptoms in patients.

How similar studies have gone: While observational studies on vitamin C deficiency exist, this specific approach using Vitamin C Injektopas® is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with vitamin C deficiency
* Age ≥ 18 years

Exclusion Criteria:

* Hypersensitivity to the active ingredient or any of the excipients
* Oxalate urolithiasis
* Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion
* Renal insufficiency
* Glucose-6-phosphate dehydrogenase deficiency/defect
* Pregnant/breastfeeding women

Where it's running

  • Multiple Physicians from Austria
    Vienna, Etc., Austria, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.